A strategic approach to global regulatory compliance for medical devices
Taking a strategic approach to achieving regulatory approval can be an effective tool in reducing the compliance burden facing medical device manufacturers. Companies that first obtain approval or clearance from the US Food and Drug Administration (FDA) for access to the US market can often leverage that clearance or approval to gain a prompt and efficient review of new device applications by regulators in other markets. This can result in faster and wider deployment of new medical technologies and help generate increased revenue from the sale of new medical devices faster.